Gunning For Generics Only, India Bans Approvals For Branded Generics, Leaving Industry In Shock
This article was originally published in The Pink Sheet Daily
Executive Summary
After planning to significantly expand the span of price controls, India takes another big step to lower the cost of medicines, but the industry questions whether the new system will fetch results.